Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/12/022320
CTRI/2019/12/022320
Not yet recruiting
未知

High HDL cholesterol and athersclerotic cardiovascular risk score

Kasturba Medical College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E789- Disorder of lipoprotein metabolism, unspecifiedHealth Condition 2: E789- Disorder of lipoprotein metabolism, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecifiedHealth Condition 2: E789- Disorder of lipoprotein metabolism, unspecified
Sponsor
Kasturba Medical College
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients in the age\-group 18\.00 years \-75 years of both sexes and who are willing to give consent will be included.
  • •High HDL cholesterol will be taken as \>50mg/dl in male, \> 60mg/dl in females
  • •Age and sex matched controls with normal HDL cholesterol will be taken

Exclusion Criteria

  • •Patient on high intensity exercise
  • •Cholesterol lowering diet
  • •Uncontrolled diabetes mellitus ( FBS \> 200mg/dl, PPBS \> 250mg/dl, HbA1C \>8%\- any
  • •Hypothyroidism (TSH \>10 )
  • •Major organ dysfunction including liver and kidney ( including nephrotic syndrome)
  • •Clinical evidence of Malignancy
  • •Steroid usage, OCPs and hormonal supplements
  • •High risk groups ( pregnant, retro positive patients)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Terminated
Not Applicable
Effects of Niacin on Good Cholesterol in People With Peripheral Arterial DiseasePeripheral Arterial Disease
NCT01391377Bayside Health7
Completed
Phase 4
Benefit of Elevation of HDL-C on Cardiovascular Outcomes in WomenCoronary Artery Disease
NCT00590629Cedars-Sinai Medical Center43
Not yet recruiting
Not Applicable
HDL and inflammatory bio markers in acute coronary syndromeHealth Condition 1: I219- Acute myocardial infarction, unspecified
CTRI/2019/06/019631Kasturba Hospital Manipal
Completed
Phase 2
Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A phase II, Multi-center, double-blind, ascending dose, placebo-controlled, dose-finding trial of CER-001 or placebo in subjects with acute coronary syndrome.Acute Coronary SyndromeHeart Attack10011082
NL-OMON38390Cerenis Therapeutics SA80
Active, not recruiting
Not Applicable
Function of High Density Lipoproteins in Acute Coronary SyndromesAcute Coronary Syndrome
NCT01278875McGill University Health Centre/Research Institute of the McGill University Health Centre65